Topic: How To Invest

Pat: What is your view on medical companies Becton Dickinson and Stryker? Thanks.

Article Excerpt

Becton Dickinson & Co., $108.00, symbol BDX on New York (Shares outstanding: 194.2 million; Market cap: $21.0 billion; www.bd.com), operates in three segments: Medical, which supplies 53% of the company’s sales, makes a broad array of devices for hospitals, doctors’ offices and other health care clients; Diagnostics (33%) sells products for collecting and shipping specimens, as well as equipment for detecting diseases; and Biosciences (14%) makes tools for studying cells. The company recently lost a lawsuit launched by Retractable Technologies, Inc. that accused it of trying to monopolize the market for safety syringes. As a result, a jury ordered Becton to pay $113.5 million in damages. However, that amount could triple to $340.5 million under anti-trust laws. The company plans to appeal this ruling. To put those figures in perspective, Becton earned $1.54 a share, excluding one-time items, in the three months September 30, 2013. That’s up 8.4% from $1.42 a share a year earlier. The latest earnings exclude a $1.06-a-share charge…